Variant report
Variant | esv3444682 |
---|---|
Chromosome Location | chr6:29952773-29957871 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr6:29955057-29955145 | GM19240 | blood: | n/a | n/a |
2 | CTCF | chr6:29955053-29955103 | Hela-S3 | cervix: | n/a | n/a |
3 | CTCF | chr6:29955140-29955290 | NHDF-neo | bronchial: | n/a | n/a |
4 | CTCF | chr6:29955055-29955143 | ProgFib | skin: | n/a | n/a |
5 | CTCF | chr6:29954660-29954810 | NHLF | lung: | n/a | n/a |
6 | CTCF | chr6:29954820-29954970 | NHLF | lung: | n/a | n/a |
7 | CTCF | chr6:29955100-29955250 | NHDF-neo | bronchial: | n/a | n/a |
8 | CTCF | chr6:29955100-29955250 | NHLF | lung: | n/a | n/a |
9 | CUX1 | chr6:29957652-29957709 | K562 | blood: | n/a | n/a |
10 | GATA3 | chr6:29956973-29957478 | SK-N-SH | brain: | n/a | n/a |
11 | SMC3 | chr6:29954969-29955199 | Hela-S3 | cervix: | n/a | n/a |
12 | STAT3 | chr6:29954079-29954279 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr6:29957034-29957392 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29949567..29951883-chr6:29956360..29958897,2 | K562 | blood: | |
2 | chr6:29943564..29948104-chr6:29950580..29953407,4 | MCF-7 | breast: | |
3 | chr6:29955944..29957540-chr6:29961326..29963329,2 | K562 | blood: | |
4 | chr6:29950039..29951645-chr6:29953140..29954748,2 | K562 | blood: | |
5 | chr6:29943470..29945184-chr6:29952031..29954167,2 | K562 | blood: | |
6 | chr6:29952453..29954719-chr6:29960794..29963085,2 | K562 | blood: | |
7 | chr6:29949567..29952384-chr6:29955471..29958344,3 | K562 | blood: | |
8 | chr6:29956108..29958898-chr6:29958953..29961030,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
DDX39BP2 | TF binding region |
ENSG00000204625 | chromatin interactions |
ENSG00000238024 | chromatin interactions |
ENSG00000224312 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375755226 | chr6:29952810-29952811 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs17186937 | chr6:29952814-29952815 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs140487876 | chr6:29952864-29952865 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs189637524 | chr6:29952875-29952876 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs17186944 | chr6:29952920-29952921 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs17186951 | chr6:29952924-29952925 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs11755966 | chr6:29952931-29952932 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs535018125 | chr6:29952986-29952987 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs111562645 | chr6:29952995-29952996 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs28559801 | chr6:29953001-29953002 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs11755984 | chr6:29953035-29953036 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
12 | rs147071875 | chr6:29953059-29953060 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs537453658 | chr6:29953080-29953081 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs11755961 | chr6:29953099-29953100 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs565497615 | chr6:29953147-29953148 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs181169863 | chr6:29953152-29953153 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs369997448 | chr6:29953185-29953186 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs373390031 | chr6:29953226-29953227 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs553163538 | chr6:29953237-29953238 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs11755992 | chr6:29953270-29953271 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs62388727 | chr6:29953274-29953275 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs11751331 | chr6:29953311-29953312 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs377492786 | chr6:29953363-29953364 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs11758493 | chr6:29953428-29953429 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs201390476 | chr6:29953440-29953441 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs11756025 | chr6:29953442-29953443 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs529825020 | chr6:29953443-29953444 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs200697028 | chr6:29953484-29953485 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs143943004 | chr6:29953505-29953506 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs201198374 | chr6:29953518-29953519 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs386698662 | chr6:29953523-29953524 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs60839982 | chr6:29953528-29953529 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs59812435 | chr6:29953532-29953533 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs146777347 | chr6:29953545-29953546 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs138937905 | chr6:29953546-29953547 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs116227464 | chr6:29953584-29953585 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs115490678 | chr6:29953594-29953595 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs73725908 | chr6:29953598-29953599 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs376143866 | chr6:29953600-29953601 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs545355857 | chr6:29953604-29953605 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs386698663 | chr6:29953626-29953627 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs73725910 | chr6:29953628-29953629 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs185608723 | chr6:29953713-29953714 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
44 | rs386698664 | chr6:29953716-29953717 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs73725912 | chr6:29953718-29953719 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs188409258 | chr6:29953729-29953730 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs116746699 | chr6:29953731-29953732 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs73428151 | chr6:29953734-29953735 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs114098293 | chr6:29953735-29953736 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
50 | rs115639092 | chr6:29953760-29953761 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Systemic lupus erythematosus | 20877625 | CNVD |
Cleidocranial dysplasia | 18696259 | CNVD |
Holoprosencephaly | 21359414 | CNVD |
Liposarcoma | 21253554 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Fibroblasts | 20926602 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Rett syndrome | 21593744 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Glioma | 20126413 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29945600-29966400 | Weak transcription | Pancreas | Pancrea |
2 | chr6:29949400-29953400 | Weak transcription | HepG2 | liver |
3 | chr6:29950200-29953600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
4 | chr6:29953400-29953800 | Enhancers | HepG2 | liver |
5 | chr6:29953600-29954400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr6:29954200-29954600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
7 | chr6:29956200-29956600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr6:29956400-29957200 | Enhancers | HMEC | breast |
9 | chr6:29956800-29957000 | Enhancers | HSMM | muscle |
10 | chr6:29956800-29957000 | Enhancers | NHEK | skin |
11 | chr6:29956800-29957200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr6:29956800-29957200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
13 | chr6:29957000-29957400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr6:29957200-29960200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr6:29957200-29960400 | Weak transcription | HMEC | breast |
16 | chr6:29957400-29957600 | Weak transcription | NHEK | skin |
17 | chr6:29957400-29960400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |